Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (17)

2024

  1. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

2022

  1. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo

    Molecular Medicine, Vol. 28, Núm. 1

2021

  1. Experimental models for pain evaluation in osteoarthritis

    Revista de la Sociedad Espanola del Dolor, Vol. 28, pp. 18-30

  2. Olfactory Neuroepithelium Cells from Cannabis Users Display Alterations to the Cytoskeleton and to Markers of Adhesion, Proliferation and Apoptosis

    Molecular Neurobiology, Vol. 58, Núm. 4, pp. 1695-1710

2020

  1. Opioid receptors mRNAs expression and opioids agonist-dependent G-protein activation in the rat brain following neuropathy

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 99

2019

  1. Chemogenetic Silencing of the Locus Coeruleus–Basolateral Amygdala Pathway Abolishes Pain-Induced Anxiety and Enhanced Aversive Learning in Rats

    Biological Psychiatry, Vol. 85, Núm. 12, pp. 1021-1035

  2. Deep brain stimulation: Mechanisms underpinning antidepressant effects

    Neurobiology of Depression: Road to Novel Therapeutics (Elsevier), pp. 375-382

2018

  1. Effect of Deep Brain Stimulation of the ventromedial prefrontal cortex on the noradrenergic system in rats

    Brain Stimulation, Vol. 11, Núm. 1, pp. 222-230

2015

  1. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease

    Psychoneuroendocrinology, Vol. 62, pp. 69-79

  2. Stress increases the negative effects of chronic pain on hippocampal neurogenesis

    Anesthesia and Analgesia, Vol. 121, Núm. 4, pp. 1078-1088

2012

  1. The Mu-opioid receptor and the NMDA receptor associate in PAG neurons: Implications in pain control

    Neuropsychopharmacology, Vol. 37, Núm. 2, pp. 338-349

2011

  1. ADAM-17/tumor necrosis factor-α-converting enzyme inhibits neurogenesis and promotes gliogenesis from neural stem cells

    Stem Cells, Vol. 29, Núm. 10, pp. 1628-1639

  2. Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model

    Behavioural Pharmacology, Vol. 22, Núm. 5-6, pp. 599-606

  3. Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain

    European Journal of Pharmacology, Vol. 655, Núm. 1-3, pp. 46-51

  4. Neurotrophins role in depression neurobiology: A review of basic and clinical evidence

    Current Neuropharmacology, Vol. 9, Núm. 4, pp. 530-552

2009

  1. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression

    International Journal of Neuropsychopharmacology, Vol. 12, Núm. 8, pp. 1033-1044

  2. Opiates as antidepressants

    Current Pharmaceutical Design, Vol. 15, Núm. 14, pp. 1612-1622